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Abstract 
The Eph-ephrin system plays pivotal roles in cell adhesion and migration. The receptor-like 
functions of the ephrin ligands allow the regulation of intracellular processes via reverse 
signaling. γ-Secretase mediated processing of ephrin-B has previously been linked to 
activation of Src, a kinase crucial for focal adhesion and podosome phosphorylation. Here, 
we analyzed the role of γ-secretase in the stimulation of reverse ephrin-B2 signaling in the 
migration of embryonic stem cell derived microglia (ESdM). The proteolytic generation of 
the ephrin-B2 intracellular domain (ICD) by γ-secretase stimulates Src and focal adhesion 
kinase (FAK). Inhibition of γ-secretase decreased the phosphorylation of Src and FAK, and 
reduced cell motility. These effects were associated with enlargement of the podosomal 
surface. Interestingly, expression of ephrin-B2 ICD could rescue these effects, indicating that 
this proteolytic fragment mediates the activation of Src and FAK, and thereby regulates 
podosomal dynamics in microglial cells. Together, these results identify γ-secretase as well as 
ephrin-B2 as regulators of microglial migration. 
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Introduction 
Eph receptors constitute a large family of receptor tyrosine kinases that are regulated by 
ephrin ligands, hereafter referred to as ephrins. The Eph-ephrin system plays fundamental 
roles in embryogenesis, development and adulthood by orchestrating cell interaction and 
migration, differentiation and cell survival (Klein and Kania 2014; Pasquale 2008). It is 
capable of bidirectional signaling, in which not only the receptors, but also the ephrins 
regulate multiple intracellular signaling pathways. The signaling via Eph receptors and 
ephrins is termed ‘forward’ and ‘reverse’ signaling, respectively (Holland et al. 1996). The 
ephrins comprise two groups. While ephrin-A family members are attached to the membrane 
by a glycosylphosphatidylinositol (GPI) anchor, ephrin-B family members are type I 
transmembrane proteins with several signaling domains in their cytoplasmic tail. It has been 
shown that several Eph receptors as well as ephrin-Bs can undergo proteolytic processing by 
ectodomain shedding and intramembranous cleavage (Atapattu et al. 2014; Georgakopoulos 
et al. 2006; Pascall and Brown 2004; Tomita et al. 2006). Ectodomain shedding involves 
proteases of the A disintegrin and metalloproteinase (ADAM) (Janes et al. 2005) or matrix-
metalloprotease (MMP) families (Tanaka et al. 2007). The resultant membrane-bound C-
terminal fragments (CTFs) can then undergo intramembranous processing by γ-secretase (De 
Strooper and Annaert 2010; Langosch et al. 2015). This type of regulated intramembranous 
proteolysis (RIP) has previously been demonstrated for ephrin-B2 (Georgakopoulos et al. 
2006), and later also for EphB2 (Litterst et al. 2007; Xu et al. 2009) and EphA4 (Inoue et al. 
2009). The γ-secretase mediated cleavage of ephrin-B2 upon EphB2 receptor binding 
regulates activity of Src in murine embryonic fibroblasts (MEF) (Georgakopoulos et al. 2011; 
Waschbusch et al. 2009).  
Src and the focal adhesion kinase (FAK/PTK2) are important kinases which regulate protein 
phosphorylation involved in the assembly and disassembly of focal adhesion sites (FAS) and 
podosomes (Frame 2004; Mitra et al. 2005; Schlaepfer and Mitra 2004). Ephrin-Bs are able 
to recruit proteins via their four Src homology (SH) 2 binding domains and their PDZ binding 
domain. Besides Src, ephrin-Bs also attract proteins like growth factor receptor bound protein 
4 (Grb4) (Cowan and Henkemeyer 2001; Segura et al. 2007), which is involved in focal 
adhesion disassembly, and PDZ-domain binding regulator of heterotrimeric G protein 
signaling (PDZ-RGS) (Lu et al. 2001), which has been shown to link ephrin-B reverse 
signaling to directed migration. Depending on the cell type, cell migration and adhesion is 
either mediated by FAS or by podosomes, which are large protein complexes localizing to 
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sites of cell-matrix interactions. Despite similar protein composition, podosomes are 
structurally different from FAS (Linder and Aepfelbacher 2003). They are mostly expressed 
by phagocytic cells with high motility.  
The formation of podosomes is also essential for migration of microglia (Vincent et al. 2012). 
Microglial migration and motility enables these cells to reach distinct locations during 
development, and in physiological and pathophysiological conditions of the adult brain. 
Microglia exert a variety of functions in the brain and are associated with different 
neurological diseases, such as multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, 
and ischemic brain diseases (Fu et al. 2014; Prinz and Priller 2014). Here, we demonstrate 
that stimulation of reverse ephrin-B2 signaling in embryonic stem cell derived microglia 
(ESdM) involves γ-secretase dependent generation of an ephrin-B2 intracellular domain 
(ICD). This proteolytic cleavage product stimulates the phosphorylation and activity of both 
c-Src and FAK. Inhibition of γ-secretase impairs reverse ephrin-B2 signaling and results in 
decreased podosome dynamics and migration of microglia. 
 
Materials and Methods 
Cell culture 
Hek293FT cells and murine primary microglia were maintained in Dulbecco´s Modified 
Eagle´s Medium (DMEM) GlutamaxTM containing 4.5 g/l D-glucose supplemented with 10 
% fetal calf serum (FCS, PAN) and 1 % Penicillin/Streptomycin solution (50 U/ml Penicillin, 
50 μg/ml Streptomycin). Murine WT and PSdKO embryonic stem cells were generated as 
described before (Herreman et al. 1999). ES cells from wild type (WT) and presenilin-1/2 
double knockout (PSdKO) mice were differentiated into microglia (ESdM) as reported 
previously (Beutner et al. 2010) and were maintained in DMEM F-12 containing 1×N2 
supplement, 0.48 mM L-glutamine, 5.3 μg/ml−1 D-glucose, HEPES and 1 % 
penicillin/streptomycin solution (50 U/ml penicillin, 50 μg/ml streptomycin) at 37°C, 95 % 
humidity and 5 % CO2 (Beutner et al. 2010). The ESdM were extensively characterized 
previously and closely resemble primary microglia under normal and stimulated conditions 
(Aslanidis et al. 2015; Beins et al. 2016; Beutner et al. 2013) FACS and semi-quantitative 
RT-PCR also that ESdM derived from PSdKO cells and transfected with PS1 WT or the 
inactive PS1 showed similar expression pattern of several surface marker proteins and 
mRNAs of myeloid cells(supplementary information, supplementary figure 1).   
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cDNA constructs, virus production and cell transduction 
For constitutive overexpression, the Lenti-X Tet-On Advanced System (Clontech, Mountain 
View, CA) was modified by replacing the cytomegalovirus promoter of the pLVX-Tet-On 
plasmid with the elongation factor 1 (EF1) α promoter, resulting in the pLVX-EF1α vector. 
The pLVX-EF1α vector was a generous gift from Dr. Jerome Mertens (University of Bonn). 
Human ephrin-B2 full-length (NM_004093.3) or fragments closely resembling the C-
terminal fragment (CTF) or intracellular domain (ICD) were amplified by PCR. PCR 
products were restricted with MluI and BamHI and ligated into the pLVX-EF1α vector. 
Production of lentiviral particles was performed as previously described (Kutner et al. 2009). 
Briefly, HEK-293FT cells were co-transfected with the packaging plasmid psPAX2, the 
envelope plasmid pMD2.G, and the respective lentiviral vector plasmid. Viral particles were 
enriched by incubation with polyethyleneglycol 6000 and consecutive centrifugation. 
Presenilin expressing and WT ESdM were transduced with the different ephrin-B2 constructs 
overnight. After antibiotic selection, cells were cultured in the presence of 2 μg/mL 
puromycin (Sigma-Aldrich). 
 
Primary antibodies  
For immunocytochemistry and Western immunoblot analysis the following antibodies were 
used: C-terminal ephrin-B Ab316 (SAB4300455, Sigma-Aldrich); N-terminal ephrin-B2: (sc-
15397, Santa Cruz), N-terminal ephrin-B2 (used in Fig.1 only; MABC127, Millipore); actin 
(A1978, Sigma-Aldrich); Cell Fractionation Antibody Sampler Kit, containing MEK1/2, AIF, 
Histone H3 and Vimentin (11843, Cell Signaling Technology); pSrc (Y418) (44660G, Life 
Technologies); Src (05-184, Millipore); pFAK (Y397) (3283S, Cell signaling technology); 
Presenilin (C-loop, rb3109, Eurogentec (Prager et al. 2007)); Phosphotyrosine (05-321, 
Millipore). 
 
Precipitation of proteins with trichloroacetic acid (TCA) 
Cell culture supernatants were collected and cleared from cellular debris by centrifugation for 
5 min at 300xg. Sodium desoxycholic acid was added to a final concentration of 0.02 % and 
incubated for 15 min. TCA was then added to a final concentration of 10 %. Next, mixtures 
were incubated for 1 h at room temperature. Precipitated proteins were collected by 
centrifugation for 15 min at 16,000xg at 4°C and washed twice with ice-cold acetone. The 
washed pellets were air-dried, resuspended in 10 µl of Tris-SDS buffer (50 mM Tris, 1 % 
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SDS in dH2O), and incubated for 10 min at 50°C. Finally, 2x LDS-sample buffer was added, 
and samples were subjected to separation by NuPAGE (Life Technologies). Image 
acquisition: ECL imager, Quantity One Software (Biorad). Densitometric analysis of Western 
blots: ImageJ software. 
 
Cell lysis and cell fractionation 
All centrifugation steps were done at 4°C, all other steps were done on ice. For whole cell 
lysis, cells were incubated 15 min with STEN lysis buffer (50 mM Tris, 150 mM NaCl, 2 
mM EDTA, 1 % Nonidet P-40, 1 % Triton X-100, dithiothreitol (DTT), pH 7.4). 
Homogenates were cleared by centrifugation for 15 min at 16000xg. For cell fractionation, 
cells were incubated in hypotonic buffer (10 mM Tris, 0.1 mM EGTA, 25 mM β-
glycerophosphate, 1 mM dH2O, pH 7.6) for 15 min, followed by passing the suspension 
through a needle. Cell nuclei were pelleted by centrifugation (10 min at 300xg and 4°C) and 
were then incubated in buffer C (25 % glycerol, 20 mM HEPES, 0.4 M NaCl, 1 mM EDTA 
(pH 8.0), 1 mM EGTA, 25 mM β-glycerophosphate, 1 mM DTT) for 15 min. The 
supernatant containing cytosolic and membrane fraction was centrifuged at 16000xg for 1 h. 
After centrifugation, the pellet containing the membrane was incubated with STEN lysis 
buffer as previously described. All buffers contained protease inhibitor (Complete, Roche) 
and phosphatase inhibitor (PhosSTOP, Roche). Membrane and nuclear fractions were again 
centrifuged for 15 min at 16000xg. Nuclear, cytosolic and membrane supernatants were 
mixed with LDS loading dye (containing 100 mM DTT), boiled for 10 min at 70°C and used 
for NuPAGE protein separation (Life Technologies). For immunoblotting, proteins were 
transferred to a nitrocellulose membrane that was then probed with the indicated antibodies. 
Bound antibodies were detected using HRP-conjugated secondary antibodies (Pierce) and 
subsequent treatment with Amersham ECL Select (GE Healthcare). Image acquisition: ECL 
imager, Quantity One Software (Biorad). Densitometric analysis of Western blots: ImageJ 
software. 
 
In-Cell Western 
Cells were seeded at 80 % confluence and cultured overnight in a 96 well dish (Vision Plate 
96, black, 4titude) under previously described conditions. Subsequently, cells were fixed with 
4 % paraformaldehyde (PFA) in TRIS buffered saline (TBS), permeabilized (TBS 
supplemented with 0.25 % Triton X-100) and incubated with blocking solution (Licor 
blocking solution:TBS, 1:1) for 1 h at RT. Then, cells were incubated with primary 
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antibodies in 5x diluted blocking solution for 1 h at RT (pSrc/Src or pFAK/FAK). Following 
antibody incubation, cells were washed and incubated with mouse IRDye 680RD (Licor) and 
with rabbit IRDye 800CW (Licor) for 1 h at RT. For detection, TBS without additives was 
added to the wells. Images were taken (quality: high, resolution: 169 µm, focus: 4 mm) with 
the Licor Odyssey CLx and brightness of wells was measured using the Image studio 
software for Odyssey. Further protocols are available at 
http://biosupport.licor.com/docs/TechNote_SubclassSpecAb.pdf. 
 
Immunocytochemistry and microscopy 
For immunocytochemistry primary microglia (5000/cm2) were seeded onto glass coverslips. 
After 48 h, cells were washed with serum free medium, 50 % of medium was removed and 
replaced by 4 % PFA in TBS. Subsequently, cells were quenched with 50 mM NH4Cl in TBS 
and permeabilized with a 0.25 % Triton X-100 solution in TBS. Unspecific binding was 
blocked by using 5 % BSA in TBS containing 0.125 % Triton X-100. After primary antibody 
incubation, cells were washed three times with washing buffer (0.125 % Triton X-100 in 
TBS), then secondary antibody (Alexa Fluor 488), 4′,6-Diamidin-2-phenylindol (DAPI) and 
phalloidin were added. After primary antibody incubation, cells were washed three times with 
washing buffer (0.125 % Triton X-100 in TBS), were mounted and imaged after 20 h with an 
AxioVert 200 fluorescence microscope with ZEN analysis Software. 
ESdM cells (5000/cm2) were seeded onto µ-dishes standard bottom (Ibidi, ibiTreat). After 24 
h cultivation, 50 % of medium was removed and replaced by 4 % PFA in TBS. Subsequently, 
cells were quenched, permeabilized and blocked like previously described. Blocking solution 
contained additional PhosSTOP (Roche) however. After primary antibody incubation, cells 
were washed three times with washing buffer (0.125 % Triton X-100 in TBS), secondary 
antibody (Alexa Fluor 488) and phalloidin were added. After three more washing steps, cells 
were imaged in dishes containing TBS. TIRF was performed on an Nikon Eclipse Ti 
fluorescence microscope with a x 100 apochromat objective and an EM-CCD camera iXon 
DU879 (Andor, Oxford). Software: NIS-elements. To analyze staining intensity, the leading 
edge of ESdM was manually delineated, mean brightness (mean brightness/area) of ROI was 
measured with ImageJ and background was subtracted. In two independent experiments, 
brightness of at least 20 cells per group/experiment was measured. 
 
Migration Assays 
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For migration assays, 15 ng/mL CX3CL1 fractalkine (R&D Systems) (according to (Napoli 
et al. 2009)) containing serum free medium was pipetted into the two filling reservoirs of the 
µ-slide chemotaxis 3D channel (Ibidi). 3x106 ESdM cells were seeded into the channel. The 
µ-slide was kept at 37°C and cells were imaged for 8 h (1 frame/5 min). Image sequences 
were manually analyzed (Manual Tracking plug in, ImageJ) and tracks were subsequently 
plotted (Chemotaxis and Migration tool, Ibidi). The accumulated distance of the ~10 fastest 
migrating cells in each group per day was statistically analyzed. 
 
Statistical analysis 
For statistical analysis either Student’s t-test (unpaired, two-sided), One-Way ANOVA (with 
Tukey’s post hoc test) or Two-Way ANOVA (with Sidak’s post hoc test) were used. 
Confidence level: 95 %. All graphs display mean of data ±SD. 
 
Results 
EphB1 receptor binding induces sequential proteolytic processing of ephrin-B2 in 
microglia 
To analyze expression and cleavage of ephrin-B2 proteins in microglia, we first used primary 
microglia isolated from mouse brain. Immunocytochemical detection with an antibody 
recognizing the ectodomain of ephrin-B2 revealed expression of endogenous ephrin-B2 in 
intracellular membranous compartments (Fig. 1A). A protein of ~ 55 kDa, consistent with the 
expected molecular mass of ephrin-B, was detected by Western immunoblotting (Fig. 1B). In 
addition, two smaller proteins of ~20 kDa and ~10 kDa were also faintly detected with an 
antibody directed against the cytoplasmic C-terminal domain of ephrin-B (1-3), indicative for 
proteolytic processing products (Fig. 1B). Especially the smaller processing products could 
only be weakly detected in primary microglia. Thus, we also sought to detect ephrin-B in 
embryonic stem cell derived microglia (ESdM) that closely resemble characteristics of 
primary microglia (Aslanidis et al. 2015; Beins et al. 2016; Beutner et al. 2013). ESdM can 
be genetically modified and cultured in larger scale allowing quantitative biochemical and 
cell biological experiments. Western immunoblotting revealed endogenous expression of 
ephrin-B. As observed with primary microglia, proteins of ~50 kDa, ~20 kDa, and ~10 kDa 
were also detected in ESdM (Fig. 1C). These data are consistent with previous results that 
indicated proteolytic processing of full-length (~50 kDa) ephrin-B2 into a membrane-bound 
C-terminal fragment (CTF; ~20 kDa), and a soluble intracellular domain (ICD, ~10 kDa) in 
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fibroblasts and Hek293 cells (Georgakopoulos et al. 2006; Tomita et al. 2006). 
Overexpression of ephrin-B2 in ESdM resulted in robust detection of the full-length (~50 
kDa) protein (Fig. 1D). The signals for the putative CTF (~20 kDa) and ICD (~14 kDa) 
increased only slightly upon overexpression of ephrin-B2. The ICD resulting from 
overexpression of ephrin-B2 FL in these cells was ~4 kDa larger than the endogenous 
fragment since it containes a C-terminal myc tag. Cell treatment with the proteasome 
inhibitor MG132 had little if any effect on the level of both fragments. The ICD was hardly 
detectable after inhibtion of the γ-secretase complex by DAPT (Fig. 1C, D), indicating that 
ICD generation involves γ-secretase activity. Since γ-secretase cleavage requires precedent 
shedding of globular ectodomains of its protein substrates, we next assessed the release of the 
ephrin-B2 ectodomain. In conditioned media, a ~30 kDa fragment corresponding to the 
secreted ectodomain (N-terminal fragment, NTF) of ephrin-B2 was detected (Fig. 2A), 
indeed suggesting constitutive processing of ephrin-B2 which results in secretion of the NTF 
and generation of a membrane-tethered CTF in microglia. Interestingly, incubation with a 
soluble variant of EphB1 significantly increased the shedding of ephrin-B2 in conditioned 
media (Fig. 2A, B), suggesting regulated proteolytic processing of ephrin-B2 upon interaction 
with EphB1. 
As observed before, the ICD was hardly dectable in cells with endogenous expression of 
ephrin-B2. However, treatment of ephrin-B2 overexpressing cells with EphB1 significantly 
increased not only the secretion of the ephrin-B2 NTFs into conditioned media, but also the 
levels of cellular CTF and ICD (Fig. 2C, D, F, G). These data indicate that interaction with its 
receptor induces sequential proteolytic processing of ephrin-B2 by ectodomain shedding and 
subsequent intramembranous cleavage of the resulting CTF. Pharmacological inhibition of γ-
secretase with DAPT led to accumulation of CTF and decreased production of the ephrin-B2 
ICD (Fig. 2H-J). To confirm the effects of γ-secretase inhibition in a genetic cellular model, 
we differentiated embryonic stem (ES) cells from presenilin 1/2 double knock out (PSdKO) 
mice into microglia and transduced them with full-length ephrin-B2 containing lentivirus. In 
PSdKO ESdM, generation of the ephrin-B2 ICD was completely abolished, while the CTF 
was significantly increased (Fig. 2H-J). These data demonstrate that the cleavage of the 
ephrin-B2 CTF and the proteolytic generation of ICD could be fully attributed to 
intramembranous cleavage by γ-secretase. 
Next, we generated ESdM expressing either the ephrin-B2 CTF or the ICD (Fig. 3A, B). 
Subcellular fractionation revealed exclusive association of full-length ephrin-B2 and its CTF 
with cellular membranes. Interestingly, the ICD was detected in the cytosolic as well as in the 
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nuclear fraction (Fig 3C, D). Cell treatment with the proteasome inhibitor MG132 strongly 
increased ICD levels, indicating efficient degradation of the ICD by the proteasome. This 
experiment shows that γ-secretase dependent ephrin-B2 cleavage allows liberation of the 
ephrin-B2 ICD from cellular membranes and its subsequent translocation into the nucleus. 
 
Activation of ephrin-B by EphB1 receptor stimulates phosphorylation of Src and FAK 
in a γ-secretase dependent manner 
To assess the effect of EphB1 receptor induced proteolytic processing on intracellular 
signaling, ephrin-B2 FL overexpressing cells were stimulated with the soluble ectodomain of 
the EphB1 receptor. Then, phosphorylation of Src, a critical kinase in ephrin-B signaling was 
detected using phosphorylation-state specific antibodies. Upon EphB1 exposure a rapid and 
transient increase in Src phosphorylation within 5 min was induced as shown by both 
Western immunoblotting (Fig. 4A, B) and In-Cell Western staining (Fig. 4C). Interestingly, 
inhibition of γ-secretase with DAPT attenuated the stimulated phosphorylation of Src (Fig. 
4D, E), indicating that EphB1 induced Src phosphorylation is dependent on γ-secretase 
activity. Very similar results were also obtained with In-Cell Western analysis of primary 
microglia (Fig. 4F, G). Cell treatment with the soluble EphB1 receptor also led to strong 
phosphorylation of FAK (Fig. 4H), a main kinase in the regulation of focal adhesion site 
dynamics and cell migration. Similar to Src, the stimulation of FAK phosphorylation by 
EphB1 also peaked at 5 min, suggesting simultaneous activation of both kinases upon EphB1 
treatment. The phosphorylation of FAK rapidly decreased reaching basal levels within 5-10 
min. after maximum stimulation (Fig. 4H). Inhibition of γ-secretase with DAPT attenuated 
the EphB1-induced phosphorylation of FAK (Fig. 4I, J). These analyses identify functional γ-
secretase as an important component in the EphB1 induced signaling to Src and FAK. 
 
Phosphorylation of Src and FAK is critically invovled in the regulation of cell adesion. To 
test the involvement of ephrin-B processing in adhesion of microglia, we first analyzed the 
effect of ephrin-B ligation with EphB1 in the absence or presence of the γ-secretase inhibitor 
DAPT on adhesion sites in the leading edge (Fig. 5A). TIRF microscopy revealed highly 
polarized distribution of adhesion sites reminiscent of podosomes containing an F-actin core 
surrounded by a ring structure consisting of highly tyrosine-phosphorylated scaffold proteins 
(Linder and Kopp 2005). Cell incubation with EphB1 significantly increased signals for pTyr 
and actin in podosomes to a very similar extent (Fig. 5 B-E). The surface of the leading edge 
did not significantly change (Fig. 5F). Surprisingly, in presence of DAPT pTyr and actin 
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brightness was also significantly increased in comparison to DMSO control treated cells 
under these conditions (Fig. 5B-E; see below and Fig. 6 and 7). 
To further link γ-secretase dependent ephrin-B processing and the activity of Src and FAK, 
we sought to establish a genetic cellular model expressing functional or inactive presenilin 1 
(PS-1). We used ESdM from PS1/2 double knock-out mice (PSdKO) that completely lack γ-
secretase activity to re-express either functional wild-type PS1 or a catalytically inactive 
variant (PS1 D385N, hereafter referred to as PS1 DN). Cells expressing PS1 WT revealed 
characteristic PS1 CTFs demonstrating efficient endoproteolytic cleavage by presenilinase 
(Fig. 6A). In contrast, the PS1 DN variant accumulated as a full-length protein. Only minor 
amounts of PS1 CTFs were detected demonstrating strongly reduced endoproteolytic 
processing and thus impaired γ-secretase activity.  
Interestingly, under unstimulated conditions in the absence of EphB1, ESdM expressing 
inactive PS1 (PS1 DN) had significantly increased pTyr and actin signals compared to cells 
expressing functional PS1 (PS1 WT; Fig. 6B, C). Moreover, PS1 WT overexpressing cells 
responded to EphB1 with increased levels of pTyr and actin in podosomes to similar extent 
and thus, the ratio of pTyr/actin was not changed (Fig. 6B-D). The average surface of the 
leading edge was also not significantly affected by the different PS genotypes or stimulation 
with EphB1 (Fig. 6E). In contrast, ESdM expressing inactive PS1 did not respond to 
stimulation with EphB1 with a further increase in pTyr and actin signals in podosomes (Fig. 
6B, C). In the presence of DAPT, pTyr and actin brightness was also significantly increased 
in comparison to DMSO control treated cells under these conditions. The data indicate a 
critical involvement of γ-secretase in the regulation of podosomes by EphB1- ephrin-B 
signaling. 
This was further supported by the finding that microglia which express inactive PS1 DN 
showed significantly decreased levels of phosphorylated Src and FAK under basal conditions 
(without stimulation by EphB1) as compared to cells expressing the functional PS1 WT (Fig. 
7A–D). Interestingly, re-expression of the ephrin-B2 ICD in PS1 DN cells strongly increased 
pSrc and pFAK (Fig. 7A-D), further supporting a critical role of the ephrin-B2 ICD generated 
by γ-secretase in the phosphorylation of Src and FAK.  
We took advantage of this genetic model to further assess the role of γ-secretase and the 
ephrin-B2 ICD in cell adhesion and migration. As observed before (Fig. 6), the signals for 
actin and pTyr per area were significantly elevated in cells expressing PS1 DN as compared 
to cells with functional PS1 WT (Fig. 8A-C). Interestingly, expression of the soluble ephrin-
B2 ICD in PS1 DN microglia normalized both actin and pTyr signals in podosomes. The 
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increased pTyr signal was proportional to that of the actin signal. Thus, the ratio of pTyr/actin 
was similar in cells expressing functional or inactive PS1 (Fig. 8D). The average area of 
leading egdes in PS1 DN expressing cells was slightly larger than in PS1 WT expressing 
cells. Additional expression of the ephrin-B2 ICD in PS1 DN normalized the size of leading 
edges comparable to that of PS1 WT cells (Fig. 8E). These findings suggest that ephrin-B2 
reverse signaling is a potent modulator of podosomal dynamics. 
 
γ-Secretase and the ephrin-B2 ICD regulate migration of microglia  
Next, we wanted to test whether these changes in podosomal cell adhesion functionally affect 
cell motility. Migration of ESdM was stimulated with the chemokine CX3CL1 and monitored 
by live cell microscopy. Cells expressing the inactive PS1 DN variant showed significantly 
decreased motility as compared to cells expressing functional PS1 WT (Fig 9A, B). 
Consistent with a critical role of the ephrin-B2 ICD in podosome dynamics, expression of the 
soluble ICD variant fully rescued the migrational deficit of PS1 DN cells (Fig. 9A, B). The 
motility of PSdKO ESdM re-expressing functional PS1 was similar to that of naïve ESdM 
expressing endogenous PS1 (Fig. 9C). In absence of CX3CL1, addition of EphB1 had little if 
any effect on migration of the cells with the different PS genotype (Fig. 9C). However, 
pharmacological inhibition of γ-secretase significantly decreased the basal motility of both 
PSdKO ESdM re-expressing functional PS1 or naïve ESdM. In contrast, γ-secretase 
inhibition did not further decrease the already low motility of PSdKO ESdM re-expressing 
the catalytically inactive PS1 DN variant (Fig. 9C). Taken together, these results implicate γ-
secretase dependent ephrin-B2 reverse signaling in the regulation of podosomal dynamics 
and microglial migration. 
 
Discussion 
 
The present data establish a functional connection of γ-secretase mediated processing of 
ephrin-B2 and podosomal turn-over in the migration of microglial cells. Primary mouse 
microglia and ESdM endogenously express ephrin-B. Western immunoblotting revealed that 
full-length ephrin-B undergoes ectodomain shedding resulting in the release of a soluble 
ectodomain and the generation of a membrane bound CTF. This CTF can undergo cleavage 
by presenilin-dependent γ-secretase activity. A similar processing pathway was demonstrated 
in a heterologous expression system previously (Georgakopoulos et al. 2006; Tomita et al. 
2006). Shedding of ephrin-B has been shown to involve MMPs (Tanaka et al. 2007) and 
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ADAMs (Janes et al. 2005; Wei et al. 2010) and is increased by interaction of ephrin-B2 with 
one of its receptors, including EphB1. Pharmacological as well as genetic inhibition of γ-
secretase by DAPT or knock out of presenilins, led to strong accumulation of the ephrin-B2 
CTF in cellular membranes and decreased the release of soluble ephrin-B2 ICD. This 
indicates that γ-secretase is responsible for RIP of ephrin-B2 in microglia. Similar ephrin-B2 
ICD generation has been reported in transfected Cos-7 cells and fibroblasts (Georgakopoulos 
et al. 2006; Tomita et al. 2006). The ephrin-B2 ICD is stabilized by proteasomal inhibition, 
suggesting efficient turn-over of the ICD in untreated cells. Interaction of ephrin-B2 with 
EphB receptors strongly increased the production of the ICD. Consistent with our previous 
data with fibroblasts (Waschbusch et al. 2009), we also observed translocation of the ephrin-
B2 ICD to the nucleus. For ephrin-B1, Tomita et al. showed that the juxtamembrane region of 
the ephrin-B1 ICD is essential for nuclear translocation (Tomita et al. 2006). Many ICDs of 
γ-secretase substrates, like those of Notch (NICD) and CD44 exert gene regulatory functions 
(Cui et al. 2006; Jarriault et al. 1995).  
In our study, we focussed on membrane proximal signaling events of ephrin-B. The 
stimulation of ephrin-B2 shedding by soluble EphB1 increased Src phosphorylation within 5 
min. Src phosphorylation was impaired by cell treatment with the γ-secretase inhibitor 
DAPT, showing that EphB1 induced Src activation is γ-secretase dependent. Additionally, 
EphB1 receptor treatment increased the phosphorylation of FAK on Y397. 
Autophosphorylation of FAK at Y397 creates a binding site for the SH2 domain of Src and 
other proteins. Upon recruitment to Y397 phosphorylated FAK, Src can further 
phosphorylate FAK at Y576 and Y577 to promote maximal FAK activity (Hanks et al. 2003; 
Mitra et al. 2005). Georgakopoulos et al. (Georgakopoulos et al. 2006; Georgakopoulos et al. 
2011) previously showed that ephrin-B2 ICD generation causes an increase of Src activity. 
The ephrin-B2 ICD was furthermore reported to bind to the Src inhibitor complex PAG/Cbp 
and Csk and to Src itself, leading to autocatalytic Src activation. In our microglial model, the 
simultaneous activation of Src and FAK upon stimulation of the EphB-ephrin-B system also 
suggests complex formation of Src and FAK resulting in increased phosphorylation and 
activation of both kinases. Interestingly, inhibition of γ-secretase suppressed activation of Src 
and FAK. These data indicate an important role for RIP of ephrin-B2 in membrane proximal 
signaling to critical components involved in FAS dynamics. For integrin-dependent stimuli 
that also promote cell motility, one of the first events associated with FAK activation, is the 
recruitment of Src kinases into a signaling complex with FAK (Schlaepfer and Mitra 2004). 
Src phosphorylation of FAK, creates binding sites for SH3 domain containing podosomal 
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proteins, such as p130 Cas. It has also been shown that cells, which express a kinase-deficient 
Src variant, also display suppressed FAK phosphorylation, indicating that the low pFAK 
levels in PSdKO PS1 DN cells may be due to decreased Src activity (Timpson et al. 2001). 
However, activation of FAK could also involve other ephrin-B binding proteins, like 
previously shown for Grb4 (Cowan and Henkemeyer 2001).  
Reverse signaling of ephrin-B proteins has been found to induce cell repulsion, cytoskeletal 
reorganization and disassembly of FAS in many cell types (Foo et al. 2006; Rudolph et al. 
2014; Tanaka et al. 2003). As mentioned above, cell types that rely on high motility, like 
macrophages, invasive cancer cells and dendritic cells, often form podosomes instead of 
FAS. Podosomes constitute a polarized pattern in the cells predetermining the direction of 
migration. They are recruited to the leading edge, which makes it a suitable cellular location 
to analyze podosomal turn-over. In this study we found that podosomal turn-over depends on 
γ-secretase activity. Surprisingly, presenilin knock out resulted in a strongly enlarged 
podosomal surface in the leading edge. This phenotype resembles the previously described 
phenotype of a Src mutant lacking its catalytic domain (Fincham et al. 2000; Kaplan et al. 
1994; Timpson et al. 2001). This Src variant, which only contains the SH2 and SH3 domains 
(AA 1-251), translocated to and caused enlargement of FAS, which were extensively 
phosphorylated despite lack of Src kinase activity (Kaplan et al. 1994). These findings 
suggest that activation of Src promotes the turn-over of FAS by stimulating FAS disassembly 
rather than FAS assembly. Furthermore, Ilic et al. showed that cells from FAK knock out 
mice displayed a larger number of FAS (Ilic et al. 1995), indicating a similar function for 
FAK. Notably, the impaired podosomal turn-over in microglia without γ-secretase activity 
could be efficiently reverted by re-expression of the soluble cytoplasmic ICD of ephrin-B2 
that resembles the product of γ-secretase cleavage. Together with the finding that Src as well 
as FAK kinase activity was inhibited by non-functional γ-secretase, these data indicate that γ-
secretase mediated processing of ephrin-B2 and liberation of its ICD from cellular 
membranes regulates podosomal turn-over via phosphorylation of Src and FAK kinase.  
The functional relevance of these findings was demonstrated by analysis of microglial 
migration. Cells with inactive γ-secretase showed significantly impaired migration. The 
present results resemble findings in kinase-deficient Src, as well as FAK knock out cells, in 
which low Src and FAK activity and enlarged FAS size were associated with reduced 
motility (Ilic et al. 1995; Kaplan et al. 1994). Consistent with an important role of the γ-
secretase dependent cleavage of ephrin-B2, expression of the soluble ICD fully restored 
microglial migration (for a schematic representation, see fig. 10). 
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Cell treatment with a soluble EphB1 receptor stimulated the phosphorylation of Src and FAK 
and was associated with an increase in podosomal surface. Surprisingly, we also found that 
cell treatment with EphB1 receptor did not increase microglial migration. The reason for this 
remains unclear. However, stimulation of microglial migration with the receptor may require 
selective binding to one side of the cell. It was previously found that binding of the receptor 
to its ligand causes retraction or attraction from or to the cell carrying the complement EphB 
receptor, in order to direct cells during development (Allen-Sharpley and Cramer 2012; 
Petros et al. 2010; Smith et al. 1997). Binding of soluble receptor to its ligand at the plasma 
membrane in a non-polarized manner, may not provide the information required for directed 
migration and therefore not stimulate migratory activity.  
The complete homology of the three human ephrin-B family members of the signaling 
domain sequence, strongly suggests a similar function in the regulation of microglial 
migration between family members. Ephrin-Bs are involved in the regulation of neuronal 
migration during development (Santiago and Erickson 2002; Senturk et al. 2011; Wang and 
Anderson 1997). Furthermore, impaired migration upon inhibition of γ-secretase has already 
been observed in other cell types. For example, the γ-secretase inhibitor DAPT or the 
overexpression of the γ-secretase substrate proteins voltage-gated sodium channel β2-subunit 
CTF and Nectin CTF inhibited migration of SH-SY5Y cells (Kim et al. 2005). Additionally, 
the γ-secretase inhibition by GSI34 has been shown to attenuate migration of two breast 
cancer cell lines (MDA MB231, 4T1) (Villa et al. 2014). We also observed impaired 
migration of primary mouse microglia upon inhibition of γ-secretase with DAPT or siRNA 
mediated knockdown of ephrin B2 (data not shown), further supporting a functional role of 
this system in the regulation microglial migration. Thus, the proteolytic processing of ephrin-
B2 by γ-secretase and its role in cell migration is observed in both ESdM and primary 
microglia. However, it will be important to assess potential quantitative differences between 
the ESdM model and authentic microglia, and also test the physiological relevance of these 
findings in vivo. 
The activation and migration of microglia could play important roles in chronic 
neuroinflammatory processes associated with several neurodegenerative diseases (Cameron 
and Landreth 2010; Heneka et al. 2015). Notably, a mutation of EphA4, a receptor that binds 
to ephrin-As as well as ephrin-Bs, has recently been associated with an increased  risk for AD 
(Hollingworth et al. 2011), suggesting an involvement of the Eph-ephrin system in AD. Cisse 
et. al furthermore found that overexpression of hippocampal EphB2, which regulates NMDA 
receptor function, could reverse long term potentiation and memory deficits in amyloid 
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precursor protein transgenic mice (Cisse et al. 2011). Our data indicate an additional role of 
this system in the regulation of microglial migration. Thus, it will be interesting to further 
investigate the potential contribution of Eph-ephrin signaling and γ-secretase in inflammation 
during neurodegeneration. 
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Figure legends 
 
Fig. 1 Endogenous expression of ephrin-B2 is in murine primary and ES cell derived 
microglia. A) Cells were stained with DAPI for nucleus, Phalloidin for actin fibers and 
ephrin-B2 with an N-terminal ephrin-B2 Ab (in upper panel). Secondary antibody control 
(lower panel) shows the specificity of ephrin-B2 detection in murine primary microglia. Scale 
bar: 20 μm. B) Detection of endogenously expressed ephrin-B (1-3) family members in 
murine primary microglia using a C-terminal ephrin-Ab by Western immunoblotting. Ephrin-
B FL (full-length) is well detectable, the ephrin-B fragments (CTF, C-terminal fragment; 
ICD, intracellular domain) are only weakly detectable at longer exposure of membranes 
(n=1). C) In ESdM, a prominent ephrin-B FL, and weaker ephrin-B fragments (ephrin-B CTF 
and ICD) were detected. Treatment with MG132 (0.1 µM, 4 h) only weakly increased the 
detection of the ephrin-B ICD levels. Treatment with DAPT (24h, 10 μM) caused decreased 
ephrin-B ICD levels as compared to the DMSO control (n=2). D) ESdM were lentivirally 
transduced to overexpress full-length ephrin-B2. Treatment with MG132 (0.1 µM, 4 h) 
increased ephrin-B ICD levels. Treatment with DAPT (24h, 10 μM) decreased ephrin-B ICD 
levels compared to the DMSO control. Images for ephrin-B2 CTF and ICD are from longer 
exposure times of membranes than the image for ephrin-B2 FL. Migration of endogenous 
ephrin-B2 ICDs and the ICD of overexpressed myc-tagged ephrin B2 are indicated by arrows 
(n=2).  
 
Fig.2: EphB1 receptor induced sequential proteolytic processing of ephrin-B2. A) ESdM 
were either treated with a control Fc-protein (Ctrl Fc) or the EphB1 receptor protein (EphB1) 
for 40 minutes. Shedding of endogenous ephrin-B (NTF, N-terminal fragment) is induced by 
treatment with EphB1 receptor. B) Quantification of A) shows significant increase of ephrin-
B NTF levels in cell culture medium (TCA precipitated) upon EphB1 receptor treatment of 
ESdM (n=3). C-G) Effects of soluble EphB1 on the proteolytic processing of overexpressed 
ephrin-B2 in ESdM. Images for ephrin-B2 CTF and ICD resulted from a longer exposure 
time than the image for ephrin-B2 FL. Cell treatment with EphB1 receptor increased levels of 
ephrin-B2 NTF in the cell culture medium (D), and of the ephrin-B2 ICD in cell lysates (G). 
Cellular levels of full-length ephrin-B2 (E), and CTFs (F) were only slightly affected by cell 
treatment with EphB1 (n=3). H-J) Analysis of WT and PSdKO ESdM cells overexpressing 
ephrin-B2 FL. Treatment with the γ-secretase inhibitor DAPT (24h, 10 μM) increased ephrin-
B2 CTF and decreased ephrin-B2 ICD in WT cells. Cells lacking γ-secretase (PSdKO) 
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showed strong accumulation of the ephrin-B2 CTF and absence of the ICD. All data are 
represented as means ± SD (n=4). 
 
Fig.3: Ephrin-B2 ICD translocates to nucleus. A) Schematic of ephrin-B2 shedding upon 
EphB1 receptor binding and cleavage by γ-secretase. 1) Upon extracellular EphB1 receptor 
binding to ephrin-B2 it is 2) shedded by ADAM secretases, producing the ephrin-B2 NTF 
and CTF, whereby the latter is still bound to the membrane. 3) Subsequently, the γ-secretase 
cleaves the ephrin-B2 CTF in its transmembrane region (TMR) to produce the ephrin-B2 
ICD. B) Schematic of ephrin-B2 FL, CTF and ICD constructs used for overexpression in 
ESdM. The ephrin-B2 ICD contains several Src homology 2 (SH2) binding domains and one 
PDZ binding domain. C) Representative blot of cell fractionation control. Membrane 
(marker: AIF), cytosol (marker: MEK1/2) and the nuclear fraction (marker: vimentin). This 
blot is representative for the fractionation control of all three samples shown in D). 
M=membrane, C=cytosol, N=nucleus. D) Cell fractionation of ESdM overexpressing the 
ephrin-B2 FL, CTF or ICD constructs. The ephrin-B2 FL and CTF are localized in the 
membrane. The ephrin-B2 ICD localizes to the cytosolic and nuclear fractions indicating 
translocation of this fragment from the cytosol to the nucleus. Cell treatment with MG132 
(0.1 µM, 4 h) strongly stabilized the ephrin-B2 ICD is efficiently degraded by the 
proteasome. 
 
Fig.4: Treatment with EphB1 receptor increases phosphorylation of Src and FAK. A, B) 
ESdM were treated with EphB1 receptor and pSrc (Y418) detected by Western 
immunoblotting. Quantification shows increased levels of pSrc after 5-20 min of treatment 
(n=2). C) In-Cell Western analysis of EphB1 receptor treatment timeline vs Ctrl Fc treatment 
shows that EphB1 causes a significant increase of pSrc after 5 and 10 min in ESdM (n=3). D) 
ESdM were treated 10 min with Ctrl Fc or EphB1 receptor upon pre-treatment with a control 
solvent or DAPT. DAPT inhibits the EphB1-induced phosphorylation of Src. E) 
Quantification of D) (n=3). F, G) In-Cell Western analysis of Src and pSrc in primary 
microglia. Stimulation with soluble EphB1 increased pSrc. Inhibition of γ-secretase with 
DAPT prevented the increase in pSrc upon cell treatment with EphB1. G) Quantification of 
F) shows that treatment with EphB1 receptor for 10 min significantly increases pSrc levels. 
This stimulation is abrogated by the inhibition of γ-secretase with DAPT (n=3). H) EphB1 
stimulation of ESdM cells causes a significant increase of pFAK levels after 5 minutes (n=3). 
I) Cells were treated 5 min with Ctrl Fc or EphB1 receptor. Pre-treatment with DAPT inhibits 
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EphB1-induced FAK phosphorylation. J) Quantification of I) (n=3). All data are represented 
as means ±SD.  
 
Fig.5: Increased podosomal surface after γ-secretase inhibition and EphB1 stimulation. 
A) Schematic view of ESdM, showing leading and trailing edge and direction of migration. 
Red dots represent podosomes; box around the leading edge indicates image section 
displayed in B). B) Total internal reflection fluorescence (TIRF) microscopy of cells treated 
with either Ctrl Fc (DMSO Ctrl Fc) or EphB1 receptor (DMSO EphB1) in the absence or 
presence of DAPT and EphB1 receptor (DAPT EphB1). ESdM were stained with phalloidin 
(red) and a phosphotyrosine (pTyr) antibody (green). Scale bar: 20 μm. C) Quantification 
shows significantly increased levels of pTyr in the leading edge of EphB1 treated cells 
compared to Ctrl Fc treated cells. D) Quantification shows significantly increased actin levels 
in DMSO EphB1 and DAPT EphB1cells compared to DMSO Ctrl Fc cells. E) Quantification 
of the ratio between pTyr and actin shows no difference, demonstrating that protein 
phosphorylation correlates to podosomal surface. F) Comparison of delineated leading edge 
sizes shows no difference between the cell types. Each group contains a minimum of 35 cells. 
Data were collected in two independent experiments. All data are represented as means ±SD. 
 
Fig.6: Impairment of γ-secretase increases the podosomal surface. A) PS1 full-length 
(FL) and C-terminal fragments (CTF) were detected by Western immunoblotting of isolated 
membranes from PSdKO cells re-expressing PS1 WT or PS1 DN (image for PS1 FL resulted 
from a longer exposure time than that for PS1 CTF). B-D) Quantification of pTyr and actin 
signals in the leading edge of cells imaged by TIRF microscopy. As compared to PSdKO 
cells re-expressing PS1 WT, PS1 DN expressing cells had significantly increased signals for 
pTyr and actin in the leading edge under unstimulated conditions. Stimulation with EphB1 
increased signals for pTyr (B) and actin (C) in PS1 WT, but not in PS1 DN expressing cells. 
The ratio between pTyr and actin was similar under all conditions (D). Each group contains a 
minimum of 35 cells. Data were obtained from two independent experiments. All data are 
represented as means ±SD. E) Quantification of the leading edge surface showed no 
significant differences under all conditions.  
 
Fig.7: Rescue of impaired phosphorylation of Src and FAK in cells without γ-secretase 
activity by re-expression of the ephrin-B2 ICD. A-D) Comparison of pSrc (A, B) and 
pFAK (C, D) levels in PSdKO cells transduced with either PS1 WT, PS1 DN or PS1 
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DN+ephrin-B2 ICD. Quantification revealed significantly reduced levels of pSrc (B) and 
pFAK (C) in PSdKO+PS1 DN cells, which can be rescued by additional stable transduction 
with ephrin-B2 ICD (n=6). All data are represented as means ±SD. 
 
Fig.8: Functional involvement of the ephrin-B2 ICD in podosome structure. A) Total 
internal reflection fluorescence (TIRF) microscopy of PSdKO cells transduced with wild type 
PS1 (WT), dominant negative PS1 (DN) and PS1 DN cells expressing the soluble B2 ICD 
(PS1 DN+B2 ICD). ESdM were stained with phalloidin (red) and a phosphotyrosine (pTyr) 
antibody (green). Scale bar: 10 μm. B-E) Quantification of pTyr (B) and actin (C) showed 
significantly increased pTyr and actin signals in the leading edge of cells with inactive PS 1 
(PS1 DN) as compared to cells with functional PS1 WT. Re-expression of the ephrin-B2 ICD 
in PS1 DN cells normalized pTyr and actin signals to that of PS1 WT expressing cells. The 
ratio of pTyr and actin was similar in all cell variants (D). The comparison of delineated 
leading edge sizes (E) shows increased size of the leading edge of PS1 DN as compared to 
PS1 WT cells. Re-expression of ephrin-B2 ICD in PS1 DN cells normalized the size if the 
leading edge to that of PS1 WT cells. Each group contains a minimum of 74 cells. Data were 
collected from two independent experiments. All data are represented as means ±SD. 
 
Fig.9: γ-Secretase dependent regulation of microglial migration. A) Representative plots 
of random ESdM migration during 8 h time lapse microscopy after stimulation with CX3CL1 
(15 ng/ml). CX3CL1 did not affect the proteolytic processing of epnrin B2 under these 
experimental conditions (not shown). B) Quantification revealed a significant reduction of the 
accumulated distance migrated by PSdKO+PS1 DN ESdM (PS1 DN) as compared to 
PSdKO+PS1 WT (PS1 WT) cells. Re-expression of the ephrin-B2 ICD in PSdKO+PS1 DN 
cells normalized migration. Each group contains a minimum of 44 cells. Data were obtained 
from three independent experiments. Manual tracking was done using ImageJ (Manual 
tracking plug-in). Plots as well as statistical data were obtained using the Ibidi chemotaxis 
and migration tool. C) Naïve ESdM cells (WT) or PSdKO cells re-expressing active PS1 WT 
(PS 1WT) or inactive PS 1 DN (PS1 DN) were treated with soluble EphB1 receptor in the 
absence or presence of DAPT. DMSO and Ctrl Fc alone served as treatment controls for 
DAPT and Eph B1Fc, respectively. Migration was analyzed as described in A, B. Migration 
of PS1 DN cells was significantly lower as compared to PS1 WT cells and naïve ESdM. 
Addition of EphB1 had no significant effect under these experimental conditions. The 
inhibition of γ-secretase with DAPT decreased the migration cells with functional γ-secretase 
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(naïve ESdM and PSdKO+PS1 WT). Each group contains a minimum of 18 cells. Data were 
collected from two independent experiments. All data are represented as means ±SD.  
 
Fig.10: Schematic view of γ-secretase dependent regulation of microglial migration. 
Upon binding of the EphB1 receptor to the extracellular domain (A), ephrin-B2 undergoes 
ectodomain shedding by ADAM’s (B). The resulting C-terminal fragment (CTF) is 
subsequently cleaved by γ-secretase within its transmembrane domain (C) thereby liberating 
the ephrin-B2 intracellular domain (ICD). The ICD can promote phosphorylation of Src and 
FAK possibly through binding to Src (D). The kinase activation of Src and FAK might 
regulate podosomal turn-over (E) and microglial migration (F). 
